Compare Wockhardt with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs PIRAMAL ENTERPRISES - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT PIRAMAL ENTERPRISES WOCKHARDT/
PIRAMAL ENTERPRISES
 
P/E (TTM) x -22.2 18.4 - View Chart
P/BV x 1.2 1.2 99.9% View Chart
Dividend Yield % 0.0 1.5 0.2%  

Financials

 WOCKHARDT   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
PIRAMAL ENTERPRISES
Mar-19
WOCKHARDT/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,0123,303 30.6%   
Low Rs5321,797 29.6%   
Sales per share (Unadj.) Rs355.9716.5 49.7%  
Earnings per share (Unadj.) Rs-60.379.7 -75.6%  
Cash flow per share (Unadj.) Rs-46.8107.9 -43.3%  
Dividends per share (Unadj.) Rs0.0128.00 0.0%  
Dividend yield (eoy) %01.1 0.1%  
Book value per share (Unadj.) Rs257.81,477.5 17.4%  
Shares outstanding (eoy) m110.63184.45 60.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.23.6 60.9%   
Avg P/E ratio x-12.832.0 -40.0%  
P/CF ratio (eoy) x-16.523.6 -69.8%  
Price / Book Value ratio x3.01.7 173.5%  
Dividend payout %035.1 -0.0%   
Avg Mkt Cap Rs m85,379470,292 18.2%   
No. of employees `0006.37.8 80.0%   
Total wages/salary Rs m9,37122,504 41.6%   
Avg. sales/employee Rs Th6,295.016,899.4 37.2%   
Avg. wages/employee Rs Th1,498.32,877.7 52.1%   
Avg. net profit/employee Rs Th-1,066.31,879.9 -56.7%   
INCOME DATA
Net Sales Rs m39,369132,153 29.8%  
Other income Rs m1,2023,128 38.4%   
Total revenues Rs m40,571135,281 30.0%   
Gross profit Rs m1866,290 0.0%  
Depreciation Rs m1,4955,202 28.7%   
Interest Rs m2,55544,097 5.8%   
Profit before tax Rs m-2,83020,119 -14.1%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2578,611 3.0%   
Profit after tax Rs m-6,66914,701 -45.4%  
Gross profit margin %050.2 0.1%  
Effective tax rate %-9.142.8 -21.2%   
Net profit margin %-16.911.1 -152.3%  
BALANCE SHEET DATA
Current assets Rs m33,796122,742 27.5%   
Current liabilities Rs m26,917310,810 8.7%   
Net working cap to sales %17.5-142.3 -12.3%  
Current ratio x1.30.4 317.9%  
Inventory Days Days7923 344.0%  
Debtors Days Days8939 229.7%  
Net fixed assets Rs m39,664116,904 33.9%   
Share capital Rs m553369 150.0%   
"Free" reserves Rs m27,968272,161 10.3%   
Net worth Rs m28,522272,530 10.5%   
Long term debt Rs m21,731270,196 8.0%   
Total assets Rs m81,620856,261 9.5%  
Interest coverage x-0.11.5 -7.4%   
Debt to equity ratio x0.81.0 76.9%  
Sales to assets ratio x0.50.2 312.5%   
Return on assets %-5.06.9 -73.4%  
Return on equity %-23.45.4 -433.4%  
Return on capital %-7.712.4 -61.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80715,200 64.5%   
Fx outflow Rs m1,7894,889 36.6%   
Net fx Rs m8,01910,312 77.8%   
CASH FLOW
From Operations Rs m684-115,975 -0.6%  
From Investments Rs m6,302-8,265 -76.3%  
From Financial Activity Rs m-7,695107,525 -7.2%  
Net Cashflow Rs m-664-16,650 4.0%  

Share Holding

Indian Promoters % 74.5 52.9 140.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 4.0 57.5%  
FIIs % 7.7 26.6 28.9%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 16.5 93.3%  
Shareholders   67,757 93,274 72.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  GSK PHARMA  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Sep 20, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS